Affiliation: Erasmus University
Country: The Netherlands
- Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second roundM E van den Akker-van Marle
Department of Public Health, Erasmus University Rotterdam, The Netherlands
Int J Cancer 73:464-9. 1997..Interval cancer rates, results of the subsequent round and size distributions are also crucial indicators of the quality of the screening programme and should be analysed in their specific context...
- Low risk of cervical cancer during a long period after negative screening in the NetherlandsM E van den Akker-van Marle
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Br J Cancer 88:1054-7. 2003..This applies also to the IARC multicountry study, and may have caused too optimistic expectations about the effectiveness of cervical cancer screening...
- Cost-effectiveness of cervical cancer screening: comparison of screening policiesM Elske van den Akker-van Marle
Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands
J Natl Cancer Inst 94:193-204. 2002..e., Pap smears). We compared the efficiency of cervical cancer-screening programs by performing a cost-effectiveness analysis of cervical cancer-screening policies from high-income countries...
- Cervical cancer screening in the NetherlandsM van Ballegooijen
Erasmus Universiteit Rotterdam, Faculty of Medicine and Health Sciences, Department of Public Health, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
Eur J Cancer 36:2244-6. 2000..At the moment short-term results of implementation of the new screening programme are becoming available. It will take many more years before long-term effects of the new programme will emerge...
- Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectivenessM van Ballegooijen
Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
Eur J Cancer 36:2177-88. 2000..The main, and to some extent, unsolvable problem for further improvement of the analysis is the lack of reliable country-specific estimates for the background risk of cervical cancer in women eligible for screening in the near future...
- Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literatureM Kyrgiou
Department of Obstetrics and Gynaecology, Victoria Hospital, Blackpool FY3 8NR, UK
Cancer Treat Rev 33:514-20. 2007..However, protracted attendance for cytological follow-up decreases with time and might put some women at risk of developing invasive disease. The aim of this review was to assess management options for women with minor cervical disease...
- European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminologyA Herbert
Guy s and St Thomas Hospital NHS Foundation Trust, London, UK
Cytopathology 18:213-9. 2007..These guidelines should allow European countries to adapt their terminology in such a way as to make their screening programmes comparable with each other as well as with programmes elsewhere in the world...
- European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytologyM Arbyn
Scientific Institute of Public Health, Brussels, Belgium, and European Cancer Network, IARC, Lyon, France
Cytopathology 18:133-9. 2007..Subsequently, the slide or vial and the completed request form are sent to the laboratory for cytological interpretation...
- Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccinationJ Dillner
WHO Global Reference Laboratory for HPV Diagnosis and Control, Department of Clinical Microbiology, University Hospital, SE 20502 Malmo, Sweden
Clin Exp Immunol 148:199-207. 2007..Internationally standardized monitoring and evaluation of prophylactic HPV vaccination programmes will be essential for arriving at the most (cost-)effective strategies for cancer control...
- European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratoriesH G Wiener
Institute of Clinical Pathology, University Vienna, Austria
Cytopathology 18:67-78. 2007..The guidelines are extensively referenced and as far as possible the recommendations are evidence-based...
- Ovarian cancer screeningM Kyrgiou
Department of Obstetrics and Gynaecology, Hammersmith Hospital, Queen Charlotte's and Chelsea Hospital, London, W12 OHS
Anticancer Res 26:4793-801. 2006..However, the conclusive end-point that would provide the acceptable level of evidence for the introduction of screening should be a reduction in mortality. Up-to-date, there is no such evidence to justify this...
- Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisationJ Verguts
Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Catholic University Leuven, Leuven, Belgium
BJOG 113:1303-7. 2006....
- Cervical cancer screening programmes and policies in 18 European countriesA Anttila
The Finnish Cancer Registry, Helsinki, Finland
Br J Cancer 91:935-41. 2004..Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations...
- Rapid pre-screening of Pap smears in quality control: an Italian experienceA Placidi
Cytopathology 15:121-3. 2004
- Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish womenC E Depuydt
Laboratory for Clinical Pathology Labo RIATOL, Antwerp, Belgium
Br J Cancer 88:560-6. 2003..7%). In Flanders, HSIL was most often associated with HPV types 16, 33, 35, 31, 18 and 51. Using thin-layer liquid-based cytology and PCR to detect HPV, it is feasible to screen large numbers of women...
- Cervical cytology biobanking: quality of DNA from archival cervical Pap-stained smearsG A V Boulet
Applied Molecular Biology Research AMBIOR, Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium
J Clin Pathol 61:637-41. 2008..This study evaluates three commercial isolation methods and one digestion procedure for their ability to obtain DNA suitable for PCR from fixed and stained Pap smears...